| 1 |
Howlader N, Forjaz G, Mooradian MJ, et al. The effect of advances in lung-cancer treatment on population mortality[J]. N Engl J Med, 2020, 383(7): 640-649.
|
| 2 |
李 丽，郭孟刚，罗晓斌，等. 基于SEER数据库分析肺腺癌的发病率及生存趋势[J]. 安徽医药，2023, 27(9): 1796-1799.
|
| 3 |
Oyouni AAA. Human papillomavirus in cancer: Infection, disease transmission, and progress in vaccines[J]. J Infect Public Health, 2023, 16(4): 626-631.
|
| 4 |
Hill M, Tran N. miRNA interplay: mechanisms and consequences in cancer[J]. Dis Model Mech, 2021, 14(4): dmm047662.
|
| 5 |
Nunvar J, Pagacova L, Vojtechova Z, et al. Lack of conserved miRNA deregulation in HPV-induced squamous cell carcinomas[J]. Biomolecules, 2021, 11(5): 764.
|
| 6 |
Song H, Zhao Z, Ma L, et al. MiR-3653 blocks autophagy to inhibit epithelial-mesenchymal transition in breast cancer cells by targeting the autophagy-regulatory genes ATG12 and AMBRA1[J]. Chin Med J (Engl), 2023, 136(17): 2086-2100.
|
| 7 |
Cui H, Zhang B, Ruan M, et al. Overexpression of miR-3653 is associated with HPV infection and serves as a biomarker in patients with cervical cancer[J]. Int J Womens Health, 2022, 14: 1037-1045.
|
| 8 |
Barta JA, Powell CA, Wisnivesky JP. Global epidemiology of lung cancer[J]. Ann Glob Health, 2019, 85(1): 8-23.
|
| 9 |
Succony L, Rassl DM, Barker AP, et al. Adenocarcinoma spectrum lesions of the lung: Detection, pathology and treatment strategies[J]. Cancer Treat Rev, 2021, 99: 102237.
|
| 10 |
Song B, Qian J, Fu J. Research progress and potential application of microRNA and other non-coding RNAs in forensic medicine[J]. Int J Legal Med, 2024, 138(2): 329-350.
|
| 11 |
Choudhary C, Sharma S, Meghwanshi KK, et al. Long non-coding RNAs in insects[J]. Animals, 2021, 11(4): 1118-1137.
|
| 12 |
Peng F, Fan H, Li S, et al. MicroRNAs in epithelial-mesenchymal transition process of cancer: Potential targets for chemotherapy[J]. Int J Mol Sci, 2021, 22(14): 7526-7544.
|
| 13 |
Ramazi S, Dadzadi M, Sahafnejad Z, et al. Epigenetic regulation in lung cancer[J]. MedComm, 2023, 4(6): e401-e446.
|
| 14 |
Ying X, Ma N, Zhang X, et al. Research progress on the molecular mechanisms of hepatic metastasis in lung cancer: a narrative review[J]. Ann Palliat Med, 2021, 10(4): 4806-4822.
|
| 15 |
郑俊斌. 肺腺癌差异表达的miRNA筛选研究[J]. 广州医科大学学报，2021, 49(5): 22-25.
|
| 16 |
Zarrilli G, Galuppini F, Angerilli V, et al. miRNAs involved in esophageal carcinogenesis and miRNA-related therapeutic perspectives in esophageal carcinoma[J]. Int J Mol Sci, 2021, 22(7): 3640.
|
| 17 |
Bai X, Xu Y, Liu Y. MicroRNA-3653-3p inhibited papillary thyroid carcinoma progression by regulating CRIPTO-1[J]. Cell Mol Biol (Noisy-le-grand), 2023, 69(14): 272-276.
|
| 18 |
Song H, Zhao Z, Ma L, et al. MiR-3653 blocks autophagy to inhibit epithelial-mesenchymal transition in breast cancer cells by targeting the autophagy-regulatory genes ATG12 and AMBRA1[J]. Chin Med J (Engl), 2023, 136(17): 2086-2100.
|
| 19 |
Zhu W, Luo X, Fu H, et al. MiR-3653 inhibits the metastasis and epithelial-mesenchymal transition of colon cancer by targeting Zeb2[J]. Pathol Res Pract, 2019, 215(10): 152577.
|
| 20 |
Hu Z, Yang C, Guo S, et al. LINC01615 activates ZEB2 through competitively binding with miR-3653-3p to promote the carcinogenesis of colon cancer cells[J]. Cell Cycle, 2022, 21(3): 228-246.
|
| 21 |
Zhang L, Zhang T, Deng Z, et al. MicroRNA？3653 inhibits the growth and metastasis of hepatocellular carcinoma by inhibiting ITGB1[J]. Oncol Rep, 2019, 41(3): 1669-1677.
|
| 22 |
Delek FSP, Tunçer ŞB, Ödemiş DA, et al. miR-3653-3p expression in PBMCs: Unveiling the diagnostic potential for ovarian cancer[J]. Biochem Genet, 2024, doi: 10.1007/s10528-024-10819-0.
|
| 23 |
刘瑞花，李晓琴，于海泉. miR-3653-3p在人肺癌细胞系中的作用及调节[C]. 2017年第十五届中国北方实验动物科技年会论文集，2017: 427-433.
|
| 24 |
Lin K, Xu T, He BS, et al. MicroRNA expression profiles predict progression and clinical outcome in lung adenocarcinoma[J]. Onco Targets Ther, 2016, 9: 5679-5692.
|
| 25 |
Su X, Liu P, Zhao H, et al. Impact of HR-HPV infection on oncological outcomes in early cervical cancer[J]. Front Oncol, 2023, 13: 1264114.
|
| 26 |
Oyouni AAA. Human papillomavirus in cancer: Infection, disease transmission, and progress in vaccines[J]. J Infect Public Health, 2023, 16(4): 626-631.
|
| 27 |
杨雪娇，吴艳飞. HPV感染及IL-1β、EGFR单核苷酸多态性与非吸烟女性肺癌的相关性研究[J]. 公共卫生与预防医学，2022, 33(6): 115-118.
|
| 28 |
Rojas L, Mayorga D, Ruiz-Patiño A, et al. Human papillomavirus infection and lung adenocarcinoma: Special benefit is observed in patients treated with immune checkpoint inhibitors[J]. ESMO Open, 2022, 7(4): 100500.
|
| 29 |
喻茂文，罗朝武，汤洪波，等. 肺癌患者人乳头瘤病毒感染对机体免疫功能的影响及与预后的关系研究[J]. 国际病毒学杂志，2022, 29(3): 226-229.
|
| 30 |
Hussen BM, Ahmadi G, Marzban H, et al. The role of HPV gene expression and selected cellular MiRNAs in lung cancer development[J]. Microb Pathog, 2021, 150: 104692.
|